Jaguar Health Inc (NASDAQ:JAGX) shares, rose in value, with the stock price up by 0.14% to the previous day’s close as strong demand from buyers drove the stock to $0.07.
Actively observing the price movement in the last trading, the stock closed the session at $0.07. The value of beta (5-year monthly) was 1.32. Referring to stock’s 52-week performance, its high was $1.22, and the low was $0.05. On the whole, JAGX has fluctuated by -48.18% over the past month.
With the market capitalization of Jaguar Health Inc currently standing at about $15.47 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024.
Analysts have estimated the company’s revenue for the quarter at $2.61 million, with a low estimate of $2.61 million and a high estimate of $2.61 million. According to the average forecast, sales growth in current quarter could jump down -19.90%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2024, the company’s y-o-y revenues would reach $9.32 million, representing a decrease of -22.00% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that JAGX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of JAGX currently trading nearly -4.97% and -11.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.16, while the 7-day volatility ratio is showing 14.88% which for the 30-day chart, stands at 17.77%. Furthermore, Jaguar Health Inc (JAGX)’s beta value is 1.39, and its average true range (ATR) is 0.01.
A comparison of Jaguar Health Inc (JAGX) with its peers suggests the former has fared considerably weaker in the market. JAGX showed an intraday change of 0.14% in last session, and over the past year, it shrunk by -88.19%%.
Data on historical trading for Jaguar Health Inc (NASDAQ:JAGX) indicates that the trading volumes over the past 10 days have averaged 48.81 million and over the past 3 months, they’ve averaged 39.76 million. According to company’s latest data on outstanding shares, there are 208.77 million shares outstanding.
Nearly 20.72% of Jaguar Health Inc’s shares belong to company insiders and institutional investors own 0.59% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.44 million shares as on Mar 15, 2024, resulting in a short ratio of 0.12. According to the data, the short interest in Jaguar Health Inc (JAGX) stood at 3.60% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 3.96 million. The stock has fallen by -51.06% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the JAGX stock heading into the next quarter.
